Edoxaban prevents VTE better than enoxaparin after total hip arthroplasty

24.08.20151750
Oral edoxaban showed superior to subcutaneous enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty, according to findings published in Thrombosis Journal.

Organic compound produced by intestinal bacteria linked to atherosclerosis, mortality

21.08.20151778
Trimethylamine-N-oxide, an organic compound produced by intestinal bacteria, was associated with coronary atherosclerosis burden and mortality among patients with chronic kidney disease in a recent study.

NAFLD may be linked to heart failure

20.08.20151620
In a cross-sectional analysis, researchers found that nonalcoholic fatty liver disease was independently associated with subclinical myocardial remodeling and dysfunction, which may indicate an association with heart failure.

TWILIGHT trial will evaluate ticagrelor without aspirin in patients with coronary stents

19.08.20152387
The Icahn School of Medicine at Mount Sinai announced the initiation of a trial that will evaluate the safety and efficacy of ticagrelor monotherapy compared with ticagrelor plus aspirin in patients implanted with a coronary stent.

APPRAISE-2: Apixaban does not affect outcomes, may increase bleeding after ACS

18.08.20151620
In patients with ACS, apixaban did not improve outcomes and was associated with increased bleeding, regardless of background concomitant antiplatelet therapy, according to new findings from the APPRAISE-2 trial.

Warfarin after ischemic stroke improves outcomes, increases time at home for patients with AF

17.08.20151452
Administering warfarin in patients with atrial fibrillation after an ischemic stroke improves long-term clinical outcomes and reduces time spent in a medical facility, according to study results published in the BMJ.

Uric acid levels predict CV events in postmenopausal women

14.08.20151637
High levels of uric acid independently predicted death and major adverse CV events in postmenopausal women, according to recent study findings.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.